Myoinositol CEST signal in animals with increased Iba-1 levels in response to an inflammatory challenge—Preliminary findings

Neuroinflammation plays an important role in the pathogenesis of a range of brain disorders. Non-invasive imaging of neuroinflammation is critical to help improve our understanding of the underlying disease mechanisms, monitor therapies and guide drug development. Generally, MRI lacks specificity to molecular imaging biomarkers, but molecular MR imaging based on chemical exchange saturation transfer (CEST) can potentially detect changes of myoinositol, a putative glial marker that may index neuroinflammation. In this pilot study we aimed to investigate, through validation with immunohistochemistry and in vivo magnetic resonance spectroscopy (MRS), whether CEST imaging can reflect the microglial response to a mild inflammatory challenge with lipopolysaccharide (LPS), in the APPSwe/ PS1 mouse model of Alzheimer’s disease and wild type controls. The response to the immune challenge was variable and did not align with genotype. Animals with a strong response to LPS (Iba1+, n = 6) showed an increase in CEST contrast compared with those who did not (Iba1-, n = 6). Changes of myoinositol levels after LPS were not significant. We discuss the difficulties of this mild inflammatory model, the role of myoinositol as a glial biomarker, and the technical challenges of CEST imaging at 0.6ppm.

[1]  J Hennig,et al.  RARE imaging: A fast imaging method for clinical MR , 1986, Magnetic resonance in medicine.

[2]  R M Henkelman,et al.  Quantitative interpretation of magnetization transfer , 1993, Magnetic resonance in medicine.

[3]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[4]  D. Leibfritz,et al.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.

[5]  R Gruetter,et al.  Automatic, localized in Vivo adjustment of all first‐and second‐order shim coils , 1993, Magnetic resonance in medicine.

[6]  R. Gruetter,et al.  In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.

[7]  J. Frahm,et al.  Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.

[8]  G. Alexander,et al.  High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. , 1999, The American journal of psychiatry.

[9]  R S Balaban,et al.  A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). , 2000, Journal of magnetic resonance.

[10]  R. Mohney,et al.  Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia , 2000, The Journal of Neuroscience.

[11]  G. B. Pike,et al.  Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI , 2001, Magnetic resonance in medicine.

[12]  L DelaBarre,et al.  The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. , 2001, Journal of magnetic resonance.

[13]  D. Wilcock,et al.  Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice , 2001, Neurobiology of Aging.

[14]  D. Morgan,et al.  Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice , 2004, Experimental Neurology.

[15]  Joanna L. Jankowsky,et al.  Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .

[16]  V. Perry,et al.  Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.

[17]  Matthew E Merritt,et al.  Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI , 2005, Magnetic resonance in medicine.

[18]  Jurgen E Schneider,et al.  In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide , 2007, Nature Medicine.

[19]  J. Sheridan,et al.  Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia , 2008, Journal of Neuroinflammation.

[20]  V. Perry,et al.  Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.

[21]  W. Rooney,et al.  MR Imaging of Inflammation during Myelin-Specific T Cell-Mediated Autoimmune Attack in the EAE Mouse Spinal Cord , 2010, Molecular Imaging and Biology.

[22]  Bennett A Landman,et al.  Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments , 2009, Magnetic resonance in medicine.

[23]  S. M. Robinson,et al.  Minimal penetration of lipopolysaccharide across the murine blood–brain barrier , 2010, Brain, Behavior, and Immunity.

[24]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[25]  Mathias Hoehn,et al.  High field BOLD response to forepaw stimulation in the mouse , 2010, NeuroImage.

[26]  Ravinder Reddy,et al.  In vivo mapping of brain myo-inositol , 2011, NeuroImage.

[27]  Cleopatra Kozlowski,et al.  An Automated Method to Quantify Microglia Morphology and Application to Monitor Activation State Longitudinally In Vivo , 2012, PloS one.

[28]  A. Sartorius,et al.  Central metabolite changes and activation of microglia after peripheral interleukin-2 challenge , 2012, Brain, Behavior, and Immunity.

[29]  Bert Vogelstein,et al.  Noninvasive imaging of infection after treatment with tumor‐homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI , 2013, Magnetic resonance in medicine.

[30]  Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain , 2013, Journal of Neuroimmune Pharmacology.

[31]  Ravinder Reddy,et al.  Imaging of glutamate neurotransmitter alterations in Alzheimer's disease , 2013, NMR in biomedicine.

[32]  Jean-Philippe Michaud,et al.  Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer’s disease-related pathology , 2013, Proceedings of the National Academy of Sciences.

[33]  A. Aguzzi,et al.  Microglia: Scapegoat, Saboteur, or Something Else? , 2013, Science.

[34]  G. L. Curran,et al.  Treatment effects in a transgenic mouse model of Alzheimer’s disease: A magnetic resonance spectroscopy study after passive immunization , 2014, Neuroscience.

[35]  S. Maier,et al.  Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis , 2014, Molecular Psychiatry.

[36]  Alan A. Wilson,et al.  Neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [18F]-FEPPA , 2014, NeuroImage.

[37]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[38]  Anthony J. Spychalla,et al.  Early Alzheimer's Disease Neuropathology Detected by Proton MR Spectroscopy , 2014, The Journal of Neuroscience.

[39]  A. Pfefferbaum,et al.  Imaging Neuroinflammation? A Perspective from MR Spectroscopy , 2014, Brain pathology.

[40]  Tao Jin,et al.  Advantages of chemical exchange‐sensitive spin‐lock (CESL) over chemical exchange saturation transfer (CEST) for hydroxyl– and amine–water proton exchange studies , 2014, NMR in biomedicine.

[41]  Sébastien Ourselin,et al.  In vivo imaging of tau pathology using multi-parametric quantitative MRI , 2015, NeuroImage.

[42]  David H. Miller,et al.  Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis. , 2015, Brain : a journal of neurology.

[43]  Ravinder Reddy,et al.  CEST signal at 2 ppm (CEST@2ppm) from Z‐spectral fitting correlates with creatine distribution in brain tumor , 2014, NMR in biomedicine.

[44]  J. O'Brien,et al.  Imaging of neuroinflammation in dementia: a review , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[45]  D. Arifin,et al.  Label-free in vivo molecular imaging of underglycosylated mucin-1 expression in tumour cells , 2015, Nature Communications.

[46]  Philippe Hantraye,et al.  The Neuroprotective Agent CNTF Decreases Neuronal Metabolites in the Rat Striatum: An in Vivo Multimodal Magnetic Resonance Imaging Study , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[47]  Alessandra Bertoldo,et al.  The methodology of TSPO imaging with positron emission tomography , 2015, Biochemical Society transactions.

[48]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[49]  Eric T. Ahrens,et al.  In Vivo Quantification of Inflammation in Experimental Autoimmune Encephalomyelitis Rats Using Fluorine-19 Magnetic Resonance Imaging Reveals Immune Cell Recruitment outside the Nervous System , 2015, PloS one.

[50]  Menglin Cheng,et al.  CEST‐MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response , 2016, NMR in biomedicine.

[51]  Sterling C. Johnson,et al.  Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[52]  R. Regatte,et al.  In vitro study of endogenous CEST agents at 3 T and 7 T. , 2016, Contrast media & molecular imaging.

[53]  Li Bai,et al.  Magnetic Resonance Spectroscopy discriminates the response to microglial stimulation of wild type and Alzheimer’s disease models , 2016, Scientific Reports.

[54]  Ravinder Reddy,et al.  Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency , 2016, Journal of neurochemistry.

[55]  M. Knopp,et al.  Investigating hydroxyl chemical exchange using a variable saturation power chemical exchange saturation transfer (vCEST) method at 3 T , 2016, Magnetic resonance in medicine.

[56]  Julien Valette,et al.  In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease , 2016, NeuroImage.

[57]  K. Fukuchi,et al.  Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression. , 2016, Biochemical and biophysical research communications.

[58]  B. Turetsky,et al.  Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum , 2017, Molecular Psychiatry.

[59]  J. Frank,et al.  On the detection of cerebral metabolic depression in experimental traumatic brain injury using Chemical Exchange Saturation Transfer (CEST)-weighted MRI , 2018, Scientific Reports.

[60]  John C Gore,et al.  Assignment of the molecular origins of CEST signals at 2 ppm in rat brain , 2017, Magnetic resonance in medicine.

[61]  S. Mallal,et al.  T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.

[62]  Li Bai,et al.  Novel Methods for Microglia Segmentation, Feature Extraction, and Classification , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[63]  Kai Zhang,et al.  Quantitative assessment of the effects of water proton concentration and water T1 changes on amide proton transfer (APT) and nuclear overhauser enhancement (NOE) MRI: The origin of the APT imaging signal in brain tumor , 2017, Magnetic resonance in medicine.

[64]  John C. Gore,et al.  Accuracy in the quantification of chemical exchange saturation transfer (CEST) and relayed nuclear Overhauser enhancement (rNOE) saturation transfer effects , 2017, NMR in biomedicine.

[65]  P. Matthews,et al.  Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis , 2017, Multiple sclerosis.